Skip to main content
. 2022 Apr 27;40(24):3313–3319. doi: 10.1016/j.vaccine.2022.04.066

Table 2.

Patients’ clinical characteristics and laboratory results at admission.

Vaccinated patients
(n = 82)
Control group
(n = 82)
p-value
Presentation symptoms
Fever 36 (43.9) 42 (51.2) 0.348
Cough 52 (65.9) 49 (59.8) 0.426
Dyspnea 20 (25.3) 18 (22) 0.615
Diarrhea 28 (34.1) 16 (19.5) 0.034
Initial examination findings
Pulse rate (/min) 60 (60–64) 78 (60–90) <0.001
SpO2 value (%) 98 (95–99) 98 (95–99) 0.687
Respiratory rate (/min) 18 (16–18) 18 (18–20) 0.004
Blood pressure (mmHg)
Systolic 110 (110–120) 120 (110–125) 0.003
Diastolic 80 (70–80) 80 (78–80) 0.022
Laboratory results at admission
Serum creatinine (mg/dL) 1.2 (0.9–1.6) 1.3 (1–1.7) 0.465
Leucocyte count (/mm3) 6000 (4500–8100) 6650 (4690–8340) 0.540
Lymphocyte count (/mm3) 1060 (760–1600) 900 (560–1370) 0.173
Hemoglobin (g/dL) 13 (11.3–14) 12.8 (11.3–14) 0.530
Platelet count (/mm3) 196 (159–258) 205 (152–271) 0.521
Serum CRP levels (mg/L) 16 (6–35) 18 (3–46) 0.972
Serum ALT levels (IU/L) 21 (15–30) 18 (14–24) 0.274
Serum AST levels (IU/L) 22 (17–32) 20 (17–27) 0.138
Serum LDH levels (IU/L) 215 (184–261) 238 (186–307) 0.243
Serum D-dimer (ng/mL) 338 (179–658) 420 (305–772) 0.057
Serum Ferritin (ng/mL) 232 (111–573) 326 (99–646) 0.556
Serum Albumin (g/dL) 4.1 (3.6–4.4) 3.7 (3.4–4.2) 0.024
Serum IL-6 (pg/mL) 1.5 (1.1–11) 1.6 (0.8–4.5) 0.637
Procalcitonin (ng/mL) 0.08 (0.04–0.21) 0.08 (0.04–0.53) 0.953

Abbreviations: SpO2: blood oxygen saturation levels; CRP: C-reactive protein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; LDH: lactate dehydrogenase; IL-6: Interleukin 6. P-values compared vaccinated patients and control group, obtained from the Chi-Square test, Fisher’s exact test, or Mann–Whitney U test. Data were presented as n (%) or median [Interquartile range 25–75] unless otherwise noted. Bold indicates statistically significant associations (p < 0.05).